Latosinska A - Search Results

1

Association of Air Pollution with a Urinary Biomarker of Biological Aging and Effect Modification by Vitamin K in the FLEMENGHO Prospective Population Study.

Martens DS, An DW, Yu YL, Chori BS, Wang C, Silva AI, Wei FF, Liu C, Stolarz-Skrzypek K, Rajzer M, Latosinska A, Mischak H, Staessen JA, Nawrot TS; (The FLEMENGHO Investigators). Martens DS, et al. Among authors: latosinska a. Environ Health Perspect. 2023 Dec;131(12):127011. doi: 10.1289/EHP13414. Epub 2023 Dec 11. Environ Health Perspect. 2023. PMID: 38078706 Free PMC article.

2

Clinical applications of capillary electrophoresis coupled to mass spectrometry in biomarker discovery: Focus on Bladder Cancer.

Latosinska A, Frantzi M, Vlahou A, Mischak H. Latosinska A, et al. Proteomics Clin Appl. 2013 Dec;7(11-12):779-93. doi: 10.1002/prca.201300038. Proteomics Clin Appl. 2013. PMID: 23970371 Review.

3

Recent progress in urinary proteome analysis for prostate cancer diagnosis and management.

Frantzi M, Latosinska A, Merseburger AS, Mischak H. Frantzi M, et al. Among authors: latosinska a. Expert Rev Mol Diagn. 2015;15(12):1539-54. doi: 10.1586/14737159.2015.1104248. Epub 2015 Oct 22. Expert Rev Mol Diagn. 2015. PMID: 26491818 Review.

4

Removal of Cell-Activating Substances Using Dialyzers With Various Permeability Profiles.

Latosinska A, Hulko M, Speidel R, Mischak H, Storr M, Krause B. Latosinska A, et al. Artif Organs. 2018 Jan;42(1):78-87. doi: 10.1111/aor.12952. Epub 2017 Jul 26. Artif Organs. 2018. PMID: 28744941 Clinical Trial.

5

Clinical Proteomics for Precision Medicine: The Bladder Cancer Case.

Latosinska A, Frantzi M, Vlahou A, Merseburger AS, Mischak H. Latosinska A, et al. Proteomics Clin Appl. 2018 Mar;12(2). doi: 10.1002/prca.201700074. Epub 2017 Oct 25. Proteomics Clin Appl. 2018. PMID: 28980455 Free article. Review.

6

Urinary CE-MS peptide marker pattern for detection of solid tumors.

Belczacka I, Latosinska A, Siwy J, Metzger J, Merseburger AS, Mischak H, Vlahou A, Frantzi M, Jankowski V. Belczacka I, et al. Among authors: latosinska a. Sci Rep. 2018 Mar 27;8(1):5227. doi: 10.1038/s41598-018-23585-y. Sci Rep. 2018. PMID: 29588543 Free PMC article.

7

Clinical Proteomics: Closing the Gap from Discovery to Implementation.

Frantzi M, Latosinska A, Kontostathi G, Mischak H. Frantzi M, et al. Among authors: latosinska a. Proteomics. 2018 Jul;18(14):e1700463. doi: 10.1002/pmic.201700463. Epub 2018 Jul 8. Proteomics. 2018. PMID: 29785737

8

Proteomics biomarkers for solid tumors: Current status and future prospects.

Belczacka I, Latosinska A, Metzger J, Marx D, Vlahou A, Mischak H, Frantzi M. Belczacka I, et al. Among authors: latosinska a. Mass Spectrom Rev. 2019 Jan;38(1):49-78. doi: 10.1002/mas.21572. Epub 2018 Jun 11. Mass Spectrom Rev. 2019. PMID: 29889308

9

Promise and Implementation of Proteomic Prostate Cancer Biomarkers.

Latosinska A, Frantzi M, Merseburger AS, Mischak H. Latosinska A, et al. Diagnostics (Basel). 2018 Aug 29;8(3):57. doi: 10.3390/diagnostics8030057. Diagnostics (Basel). 2018. PMID: 30158500 Free PMC article. Review.

10

Urinary proteomic biomarkers in oncology: ready for implementation?

Frantzi M, Latosinska A, Belczacka I, Mischak H. Frantzi M, et al. Among authors: latosinska a. Expert Rev Proteomics. 2019 Jan;16(1):49-63. doi: 10.1080/14789450.2018.1547193. Epub 2018 Nov 15. Expert Rev Proteomics. 2019. PMID: 30412678

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

86 results

Search Page

Filters